REGULATORY COMPLIANCE – Page 33

Inadequate worst-case selection during site expansion – CAPA and revalidation strategy

Recognizing the symptoms of inadequate worst-case selection is critical for timely intervention. Here are key signals that may indicate underlying issues:Click to read the full article.

Record retention failures during system operation – CAPA and revalidation strategy

Identifying the symptoms of record retention failures is the first step in mitigation. These signals vary across departments but can include:Click to read the full article.

GLP study documentation gaps during regulatory inspection – preventing repeat GLP findings

Addressing GLP Study Documentation Deficiencies During Regulatory Inspections In the pharmaceutical industry, ensuring compliance with Good Laboratory Practices (GLP) is essential for maintaining product integrity and regulatory compliance. GLP study…

Inadequate worst-case selection during lifecycle management – preventing repeat validation findings

Recognizing early indicators of inadequate worst-case selection is critical. Typical symptoms include:Click to read the full article.

Electronic signatures misused during compliance audit – CAPA and revalidation strategy

Recognizing early signs of improper electronic signature usage can prevent further issues. Here are common symptoms to observe:Click to read the full article.

Validation gaps identified during change control – preventing repeat validation findings

Recognizing initial warning signs is crucial for effective intervention. Symptoms may present in various forms, including:Click to read the full article.

System access controls weak during inspection walkthrough – 21 CFR Part 11 compliance gaps

When exploring system access controls, it's essential to recognize specific symptoms indicative of weaknesses. Look out for the following on the shop floor or in laboratory settings:Click to read the…

Inadequate worst-case selection during change control – risk-based validation alignment

The first step in addressing inadequate worst-case selection is recognizing its symptoms during day-to-day operations. Signals might vary across different sectors (production, quality control, etc.) but typically include:Click to read…

Raw data traceability failure during study reconstruction – inspection deficiency risk analysis

Identifying symptoms of raw data traceability failure is the first step in the problem-solving process. Signs may include:Click to read the full article.

Validation gaps identified during change control – regulatory deficiency risk

Identifying symptoms indicative of validation gaps during the change control process is crucial for timely intervention. Here are common signals to observe:Click to read the full article.

Validation gaps identified during site expansion – regulatory deficiency risk

Identifying the symptoms or signals of validation gaps early is crucial in preventing regulatory issues. Common indicators may include:Click to read the full article.

Change impact not assessed during change control – inspection evidence expectations

Identifying the symptoms of inadequate change impact assessment is crucial for early intervention. Here are key indicators that should alert your team:Click to read the full article.